The selected newsroom is already in your list of favorites. Go to My Favorites

Our News on Newswise

International Lung Cancer Experts Seek Public Comments on Updated Molecular Testing Guideline to Improve Patient Selection and Targeted Therapies

The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) announced today the open comment period for the revised 2018 evidence-based guideline,...
22-Aug-2024 10:05 AM EDT Add to Favorites

Association for Molecular Pathology Files Lawsuit Against FDA to Challenge Final Rule on Regulation for Laboratory Developed Testing Procedures

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, and world-renowned pathologist Michael Laposata, MD, PhD, today announced the filing of a lawsuit challenging the recent U.S. Food and Drug...
19-Aug-2024 8:05 PM EDT Add to Favorites

Association for Molecular Pathology Announces 2024 Award Recipients

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today announced the recipients of this year’s Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership, and Meritorious Service...
29-Jul-2024 12:05 PM EDT Add to Favorites

Association for Molecular Pathology Publishes Recommendations to Facilitate Design and Implementation of Clinical Pharmacogenomic DPYD Genotyping Assays

The manuscript, “DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the AMP, American College of Medical Genetics and Genomics (ACMG), Clinical Pharmacogenetics Implementation Consortium (CPIC), College of American Pathologists...
22-Jul-2024 11:05 AM EDT Add to Favorites

Association for Molecular Pathology Publishes Evidence-based Recommendations for Tumor Mutational Burden Testing

The Association for Molecular Pathology (AMP) has published a set of evidence-based recommendations for the analytical validation and reporting of tumor mutational burden (TMB) testing as a potential predictive biomarker for immune checkpoint...
6-Jun-2024 11:05 AM EDT Add to Favorites

Association for Molecular Pathology to Provide Preliminary Analysis of the FDA’s Final Rule on Laboratory Developed Testing Procedures

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, will host a free webinar on the US Food and Drug Administration (FDA) final rule that seeks to regulate laboratory developed tests (LDTs)...
6-May-2024 12:05 PM EDT Add to Favorites

Association for Molecular Pathology Releases Survey Findings and Recommendations to Improve Implementation of European Union’s In Vitro Diagnostic Regulation

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released the results of its Impacts of the European Union (EU) In Vitro Diagnostic Regulation (IVDR) Survey. The anonymous survey was...
20-Feb-2024 10:05 AM EST Add to Favorites

Association for Molecular Pathology Publishes Best Practice Guidance for Designing and Utilizing Slice Testing Approach for Diagnostics

The Association for Molecular Pathology (AMP) has published a report that explores specific considerations for a slice testing strategy for diagnostics, including gene selection, analytic performance, coverage, quality, and interpretation.
20-Dec-2023 9:05 AM EST Add to Favorites


See All News

Our Experts on Newswise

Our experts are coming soon...

About

The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. AMP's 2,500+ members practice in the various disciplines of molecular diagnostics, including bioinformatics, infectious diseases, inherited conditions, and oncology. They include individuals from academic and community medical centers, government, and industry; including pathologist and doctoral scientist laboratory directors; basic and translational scientists; technologists; and trainees. Through the efforts of its Board of Directors, Committees, Working Groups, and members, AMP is the primary resource for expertise, education, and collaboration in one of the fastest growing fields in healthcare. AMP members influence policy and regulation on the national and international levels, ultimately serving to advance innovation in the field and protect patient access to high quality, appropriate testing.

Experts

Twitter

close
0.27688